Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Int J Cancer. 2014 Jun 19;136(2):476–486. doi: 10.1002/ijc.29007

Table III.

5HLDS(15)BA(Y) redirected T cell cytotoxicity of human tumor cell lines

Tumor type Cell lines GD2
expression
(MFI)
Maximum
level of lysis
Tumor
cytotoxicity
(EC50)(nM)
Melanoma SKMEL-1 38 36% 0.01
Neuroblastoma LAN-1 201 52% 0.04
Neuroblastoma NMB-7 127 60% 0.05
Melanoma M14 50 50% 0.09
Neuroblastoma BE(1)N 94 46% 0.17
Neuroblastoma IMR-32 128 58% 0.20
Melanoma HT-144 13 35% 0.48
Small cell lung
cancer
NCI-H524 66 58% 0.61
Neuroblastoma SKNJC2 6 25% 0.86*
Melanoma SKMEL28 8 28% 2.20*
small cell lung
cancer
NCI-H69 27 39% 3.16*
Breast Cancer MDA-MB-468 6 13% 3.89*
small cell lung
cancer
NCI-H196 8 7% > 185
small cell lung
cancer
NCI-H345 7 2% >185

GD2 expression of cell lines were expressed as mean fluoresce intensity. Cytotoxicity assays (51Cr release) were carried out with cultured T cells at E: T ratio of 10:1. Maximum level of lysis was measured at a 18.5 nM concentration of 5HLDS(15)BA (Y). EC50 was calculated using Sigma plot 8.0.

*

Numbers were extrapolated by Sigma plot 8.0.